Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461629 · ClinicalTrials.gov registry record
Self-management and Cognitive Function in Adults With Heart Failure
A clinical trial, sponsored by Kent State University.
- Completed
- Registry status
- 372
- Enrollment target
NCT01461629: Completed study, sponsored by Kent State University.
NCT01461629 is a clinical trial that has completed, run by Kent State University. The registered enrollment target is 372 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461629 has completed, sponsored by Kent State University.
- COMPLETED
- Registry status
- 372 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the relationship between cognitive impairment, patient self-management, health, and health service use in adults with heart failure (NYHA Class 2 and 3). The research questions are: 1. How is cognitive impairment (memory, attention, global and executive function) related to various aspects of impaired self-management (knowledge of adherence, adherence to sodium restriction and medications, symptom monitoring of weight changes, and decision and action to seek care)? 2. How are these relationships altered when adjusting for medical, demographic, and psychosocial factors? 3. What are the relationships among degree of cognitive impairment, quality self-management, health status, and health service use?
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 372 participants |
| Start Date | 2010-06 |
What the finished NCT01461629 record still lists
NCT01461629 is an observational study that tracks outcomes without assigning an intervention. The registered 372 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01461629 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01461629 about?
NCT01461629 is a clinical study titled "Self-management and Cognitive Function in Adults With Heart Failure". The purpose of this study is to assess the relationship between cognitive impairment, patient self-management, health, and health service use in adults with heart failure (NYHA Class 2 and 3). The research questions are: 1. How is cognitive impairment (memory, attention, global and executive functi...
What is the current status of trial NCT01461629?
This trial is currently completed. The enrollment target is 372 participants. The study started on 2010-06.
Who is sponsoring clinical trial NCT01461629?
This trial is sponsored by Kent State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- NCT05318105 · 372 participants · NA
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
- NCT06797635 · 372 participants · Phase 2
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia